Recent Advances in Fluorescent Arylboronic Acids for Glucose Sensing

Continuous glucose monitoring (CGM) is crucial in order to avoid complications caused by change in blood glucose for patients suffering from diabetes mellitus. The long-term consequences of high blood glucose levels include damage to the heart, eyes, kidneys, nerves and other organs, among others,...

Full description

Bibliographic Details
Main Authors: Jon Stefan Hansen, Jørn Bolstad Christensen
Format: Article
Language:English
Published: MDPI AG 2013-12-01
Series:Biosensors
Subjects:
Online Access:http://www.mdpi.com/2079-6374/3/4/400
id doaj-1738ba2602404bacb1dcaaca5768b60e
record_format Article
spelling doaj-1738ba2602404bacb1dcaaca5768b60e2020-11-24T23:34:06ZengMDPI AGBiosensors2079-63742013-12-013440041810.3390/bios3040400bios3040400Recent Advances in Fluorescent Arylboronic Acids for Glucose SensingJon Stefan Hansen0Jørn Bolstad Christensen1Department of Chemistry, University of Copenhagen, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Copenhagen, DenmarkDepartment of Chemistry, University of Copenhagen, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Copenhagen, DenmarkContinuous glucose monitoring (CGM) is crucial in order to avoid complications caused by change in blood glucose for patients suffering from diabetes mellitus. The long-term consequences of high blood glucose levels include damage to the heart, eyes, kidneys, nerves and other organs, among others, caused by malign glycation of vital protein structures. Fluorescent monitors based on arylboronic acids are promising candidates for optical CGM, since arylboronic acids are capable of forming arylboronate esters with 1,2-cis-diols or 1,3-diols fast and reversibly, even in aqueous solution. These properties enable arylboronic acid dyes to provide immediate information of glucose concentrations. Thus, the replacement of the commonly applied semi-invasive and non-invasive techniques relying on glucose binding proteins, such as concanavalin A, or enzymes, such as glucose oxidase, glucose dehydrogenase and hexokinases/glucokinases, might be possible. The recent progress in the development of fluorescent arylboronic acid dyes will be emphasized in this review.http://www.mdpi.com/2079-6374/3/4/400continuous glucose monitoringarylboronic acidsfluorescenceselectivityimmobilizationdiabetes mellitus
collection DOAJ
language English
format Article
sources DOAJ
author Jon Stefan Hansen
Jørn Bolstad Christensen
spellingShingle Jon Stefan Hansen
Jørn Bolstad Christensen
Recent Advances in Fluorescent Arylboronic Acids for Glucose Sensing
Biosensors
continuous glucose monitoring
arylboronic acids
fluorescence
selectivity
immobilization
diabetes mellitus
author_facet Jon Stefan Hansen
Jørn Bolstad Christensen
author_sort Jon Stefan Hansen
title Recent Advances in Fluorescent Arylboronic Acids for Glucose Sensing
title_short Recent Advances in Fluorescent Arylboronic Acids for Glucose Sensing
title_full Recent Advances in Fluorescent Arylboronic Acids for Glucose Sensing
title_fullStr Recent Advances in Fluorescent Arylboronic Acids for Glucose Sensing
title_full_unstemmed Recent Advances in Fluorescent Arylboronic Acids for Glucose Sensing
title_sort recent advances in fluorescent arylboronic acids for glucose sensing
publisher MDPI AG
series Biosensors
issn 2079-6374
publishDate 2013-12-01
description Continuous glucose monitoring (CGM) is crucial in order to avoid complications caused by change in blood glucose for patients suffering from diabetes mellitus. The long-term consequences of high blood glucose levels include damage to the heart, eyes, kidneys, nerves and other organs, among others, caused by malign glycation of vital protein structures. Fluorescent monitors based on arylboronic acids are promising candidates for optical CGM, since arylboronic acids are capable of forming arylboronate esters with 1,2-cis-diols or 1,3-diols fast and reversibly, even in aqueous solution. These properties enable arylboronic acid dyes to provide immediate information of glucose concentrations. Thus, the replacement of the commonly applied semi-invasive and non-invasive techniques relying on glucose binding proteins, such as concanavalin A, or enzymes, such as glucose oxidase, glucose dehydrogenase and hexokinases/glucokinases, might be possible. The recent progress in the development of fluorescent arylboronic acid dyes will be emphasized in this review.
topic continuous glucose monitoring
arylboronic acids
fluorescence
selectivity
immobilization
diabetes mellitus
url http://www.mdpi.com/2079-6374/3/4/400
work_keys_str_mv AT jonstefanhansen recentadvancesinfluorescentarylboronicacidsforglucosesensing
AT jørnbolstadchristensen recentadvancesinfluorescentarylboronicacidsforglucosesensing
_version_ 1725529589120237568